Quality Control of Herbal Medicines and Related Areas 2011
DOI: 10.5772/19894
|View full text |Cite
|
Sign up to set email alerts
|

Method Development and Validation of Analytical Procedures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“… The variance and standard deviation of the response, denoted as σ, and the slope of the calibration curve, denoted as S, are important variables in this context.  The value of S can be determined by utilizing the calibration curve of the analyte [33].…”
Section: Limit Of Quantitationmentioning
confidence: 99%
“… The variance and standard deviation of the response, denoted as σ, and the slope of the calibration curve, denoted as S, are important variables in this context.  The value of S can be determined by utilizing the calibration curve of the analyte [33].…”
Section: Limit Of Quantitationmentioning
confidence: 99%
“…The LOQ was evaluated as the concentration that produced a peak with a signal-to-noise ratio of about 10. Specificity Chromatographic profiles : Solutions of albuterol formulation containing about 75g/mL were individually prepared and chromatographed [17]. Retention times and relative retention times were determined to evaluate the potential co-elution or interference to the determination of albuterol and/or the related substances.…”
Section: Limit Of Detection (Lod) and Limit Of Quantitation (Loq)mentioning
confidence: 99%
“…The stability of albuterol in prepared standard and sample solutions was evaluated under refrigerated condition. The assay values obtained at the end of the storage period were compared to the initial concentrations to evaluate the stability of solutions [17], [21], [22].…”
Section: Stability Of Standard and Sample Solutionsmentioning
confidence: 99%
“…Under these circumstances, the pharmacopoeias may not provide standards and analytical techniques for these medications. Thus, the creation of more modern analytical techniques for such medications is required [4] . The development of analytical methods must follow the guidelines outlined in the International Conference on Harmonization (ICH) recommendations (Q2A and Q2B) and should be done in accordance with good manufacturing practise (GMP) and good laboratory practise (GLP) conditions .…”
Section: Introductionmentioning
confidence: 99%
“…The development of analytical methods must follow the guidelines outlined in the International Conference on Harmonization (ICH) recommendations (Q2A and Q2B) and should be done in accordance with good manufacturing practise (GMP) and good laboratory practise (GLP) conditions . [ 4,5] The ongoing process of method development moves on in lockstep with the development of the therapeutic product. The goal and purpose of the method should reflect the phase of drug development.…”
Section: Introductionmentioning
confidence: 99%